Global Vaccine Adjuvants Market Research Report 2020

Published On: Jan 2020

Format: PDF

Publisher: QY Research

Pages: 124

Report ID: 91314


The global Vaccine Adjuvants market is valued at 686.4 million US$ in 2020 is expected to reach 1364.7 million US$ by the end of 2026, growing at a CAGR of 10.2% during 2021-2026.
This report focuses on Vaccine Adjuvants volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Vaccine Adjuvants market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.
Market Segment Analysis
The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type, the Vaccine Adjuvants market is segmented into
Oral
Subcutaneous
Intramuscular
Others

Segment by Application
Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications)
Human Vaccine Adjuvants (Research Applications, Commercial Applications)

Global Vaccine Adjuvants Market: Regional Analysis
The Vaccine Adjuvants market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Vaccine Adjuvants market report are:
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Global Vaccine Adjuvants Market: Competitive Analysis
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Vaccine Adjuvants market include:
SEPPIC
SDA BIO
Croda International Plc
SPI Pharma
Phibro Animal Health Corporation
Tj Kaiwei
Novavax
Zhuoyue
Aphios
GSK
CSL Limited
Brenntag Biosector
SEPPIC
SPI Pharma
Novavax
Avanti Polar Lipids
Aphios

Table of Contents

1 Vaccine Adjuvants Market Overview
1.1 Product Overview and Scope of Vaccine Adjuvants
1.2 Vaccine Adjuvants Segment by Type
1.2.1 Global Vaccine Adjuvants Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Oral
1.2.3 Subcutaneous
1.2.4 Intramuscular
1.2.5 Others
1.3 Vaccine Adjuvants Segment by Application
1.3.1 Vaccine Adjuvants Sales Comparison by Application: 2020 VS 2026
1.3.2 Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications)
1.3.3 Human Vaccine Adjuvants (Research Applications, Commercial Applications)
1.4 Global Vaccine Adjuvants Market Size Estimates and Forecasts
1.4.1 Global Vaccine Adjuvants Revenue 2015-2026
1.4.2 Global Vaccine Adjuvants Sales 2015-2026
1.4.3 Vaccine Adjuvants Market Size by Region: 2020 Versus 2026

2 Global Vaccine Adjuvants Market Competition by Manufacturers
2.1 Global Vaccine Adjuvants Sales Market Share by Manufacturers (2015-2020)
2.2 Global Vaccine Adjuvants Revenue Share by Manufacturers (2015-2020)
2.3 Global Vaccine Adjuvants Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Vaccine Adjuvants Manufacturing Sites, Area Served, Product Type
2.5 Vaccine Adjuvants Market Competitive Situation and Trends
2.5.1 Vaccine Adjuvants Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Vaccine Adjuvants Players (Opinion Leaders)

3 Vaccine Adjuvants Retrospective Market Scenario by Region
3.1 Global Vaccine Adjuvants Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Vaccine Adjuvants Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Vaccine Adjuvants Market Facts & Figures by Country
3.3.1 North America Vaccine Adjuvants Sales by Country
3.3.2 North America Vaccine Adjuvants Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Vaccine Adjuvants Market Facts & Figures by Country
3.4.1 Europe Vaccine Adjuvants Sales by Country
3.4.2 Europe Vaccine Adjuvants Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Vaccine Adjuvants Market Facts & Figures by Region
3.5.1 Asia Pacific Vaccine Adjuvants Sales by Region
3.5.2 Asia Pacific Vaccine Adjuvants Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Vaccine Adjuvants Market Facts & Figures by Country
3.6.1 Latin America Vaccine Adjuvants Sales by Country
3.6.2 Latin America Vaccine Adjuvants Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Vaccine Adjuvants Market Facts & Figures by Country
3.7.1 Middle East and Africa Vaccine Adjuvants Sales by Country
3.7.2 Middle East and Africa Vaccine Adjuvants Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Vaccine Adjuvants Historic Market Analysis by Type
4.1 Global Vaccine Adjuvants Sales Market Share by Type (2015-2020)
4.2 Global Vaccine Adjuvants Revenue Market Share by Type (2015-2020)
4.3 Global Vaccine Adjuvants Price Market Share by Type (2015-2020)
4.4 Global Vaccine Adjuvants Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Vaccine Adjuvants Historic Market Analysis by Application
5.1 Global Vaccine Adjuvants Sales Market Share by Application (2015-2020)
5.2 Global Vaccine Adjuvants Revenue Market Share by Application (2015-2020)
5.3 Global Vaccine Adjuvants Price by Application (2015-2020)

6 Company Profiles and Key Figures in Vaccine Adjuvants Business
6.1 SEPPIC
6.1.1 Corporation Information
6.1.2 SEPPIC Description, Business Overview and Total Revenue
6.1.3 SEPPIC Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020)
6.1.4 SEPPIC Products Offered
6.1.5 SEPPIC Recent Development
6.2 SDA BIO
6.2.1 SDA BIO Vaccine Adjuvants Production Sites and Area Served
6.2.2 SDA BIO Description, Business Overview and Total Revenue
6.2.3 SDA BIO Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020)
6.2.4 SDA BIO Products Offered
6.2.5 SDA BIO Recent Development
6.3 Croda International Plc
6.3.1 Croda International Plc Vaccine Adjuvants Production Sites and Area Served
6.3.2 Croda International Plc Description, Business Overview and Total Revenue
6.3.3 Croda International Plc Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Croda International Plc Products Offered
6.3.5 Croda International Plc Recent Development
6.4 SPI Pharma
6.4.1 SPI Pharma Vaccine Adjuvants Production Sites and Area Served
6.4.2 SPI Pharma Description, Business Overview and Total Revenue
6.4.3 SPI Pharma Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020)
6.4.4 SPI Pharma Products Offered
6.4.5 SPI Pharma Recent Development
6.5 Phibro Animal Health Corporation
6.5.1 Phibro Animal Health Corporation Vaccine Adjuvants Production Sites and Area Served
6.5.2 Phibro Animal Health Corporation Description, Business Overview and Total Revenue
6.5.3 Phibro Animal Health Corporation Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Phibro Animal Health Corporation Products Offered
6.5.5 Phibro Animal Health Corporation Recent Development
6.6 Tj Kaiwei
6.6.1 Tj Kaiwei Vaccine Adjuvants Production Sites and Area Served
6.6.2 Tj Kaiwei Description, Business Overview and Total Revenue
6.6.3 Tj Kaiwei Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Tj Kaiwei Products Offered
6.6.5 Tj Kaiwei Recent Development
6.7 Novavax
6.6.1 Novavax Vaccine Adjuvants Production Sites and Area Served
6.6.2 Novavax Description, Business Overview and Total Revenue
6.6.3 Novavax Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Novavax Products Offered
6.7.5 Novavax Recent Development
6.8 Zhuoyue
6.8.1 Zhuoyue Vaccine Adjuvants Production Sites and Area Served
6.8.2 Zhuoyue Description, Business Overview and Total Revenue
6.8.3 Zhuoyue Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Zhuoyue Products Offered
6.8.5 Zhuoyue Recent Development
6.9 Aphios
6.9.1 Aphios Vaccine Adjuvants Production Sites and Area Served
6.9.2 Aphios Description, Business Overview and Total Revenue
6.9.3 Aphios Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Aphios Products Offered
6.9.5 Aphios Recent Development
6.10 GSK
6.10.1 GSK Vaccine Adjuvants Production Sites and Area Served
6.10.2 GSK Description, Business Overview and Total Revenue
6.10.3 GSK Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020)
6.10.4 GSK Products Offered
6.10.5 GSK Recent Development
6.11 CSL Limited
6.11.1 CSL Limited Vaccine Adjuvants Production Sites and Area Served
6.11.2 CSL Limited Vaccine Adjuvants Description, Business Overview and Total Revenue
6.11.3 CSL Limited Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020)
6.11.4 CSL Limited Products Offered
6.11.5 CSL Limited Recent Development
6.12 Brenntag Biosector
6.12.1 Brenntag Biosector Vaccine Adjuvants Production Sites and Area Served
6.12.2 Brenntag Biosector Vaccine Adjuvants Description, Business Overview and Total Revenue
6.12.3 Brenntag Biosector Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Brenntag Biosector Products Offered
6.12.5 Brenntag Biosector Recent Development
6.13 SEPPIC
6.13.1 SEPPIC Vaccine Adjuvants Production Sites and Area Served
6.13.2 SEPPIC Vaccine Adjuvants Description, Business Overview and Total Revenue
6.13.3 SEPPIC Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020)
6.13.4 SEPPIC Products Offered
6.13.5 SEPPIC Recent Development
6.14 SPI Pharma
6.14.1 SPI Pharma Vaccine Adjuvants Production Sites and Area Served
6.14.2 SPI Pharma Vaccine Adjuvants Description, Business Overview and Total Revenue
6.14.3 SPI Pharma Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020)
6.14.4 SPI Pharma Products Offered
6.14.5 SPI Pharma Recent Development
6.15 Novavax
6.15.1 Novavax Vaccine Adjuvants Production Sites and Area Served
6.15.2 Novavax Vaccine Adjuvants Description, Business Overview and Total Revenue
6.15.3 Novavax Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020)
6.15.4 Novavax Products Offered
6.15.5 Novavax Recent Development
6.16 Avanti Polar Lipids
6.16.1 Avanti Polar Lipids Vaccine Adjuvants Production Sites and Area Served
6.16.2 Avanti Polar Lipids Vaccine Adjuvants Description, Business Overview and Total Revenue
6.16.3 Avanti Polar Lipids Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020)
6.16.4 Avanti Polar Lipids Products Offered
6.16.5 Avanti Polar Lipids Recent Development
6.17 Aphios
6.17.1 Aphios Vaccine Adjuvants Production Sites and Area Served
6.17.2 Aphios Vaccine Adjuvants Description, Business Overview and Total Revenue
6.17.3 Aphios Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020)
6.17.4 Aphios Products Offered
6.17.5 Aphios Recent Development

7 Vaccine Adjuvants Manufacturing Cost Analysis
7.1 Vaccine Adjuvants Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Vaccine Adjuvants
7.4 Vaccine Adjuvants Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Vaccine Adjuvants Distributors List
8.3 Vaccine Adjuvants Customers

9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis

10 Global Market Forecast
10.1 Global Vaccine Adjuvants Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Vaccine Adjuvants by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Vaccine Adjuvants by Type (2021-2026)
10.2 Vaccine Adjuvants Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Vaccine Adjuvants by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Vaccine Adjuvants by Application (2021-2026)
10.3 Vaccine Adjuvants Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Vaccine Adjuvants by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Vaccine Adjuvants by Region (2021-2026)
10.4 North America Vaccine Adjuvants Estimates and Projections (2021-2026)
10.5 Europe Vaccine Adjuvants Estimates and Projections (2021-2026)
10.6 Asia Pacific Vaccine Adjuvants Estimates and Projections (2021-2026)
10.7 Latin America Vaccine Adjuvants Estimates and Projections (2021-2026)
10.8 Middle East and Africa Vaccine Adjuvants Estimates and Projections (2021-2026)
11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer